Home » Topics » Regulatory

Regulatory
RSS

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

CollaGenex signs European marketing agreement for Periostat

Aug. 30, 1996

Minoxidil effective and safe for chemotherapy-induced hair loss in women

Aug. 30, 1996

Lidocaine topical patch effective in treating post-herpetic neuralgia

Aug. 30, 1996

Humatrope approved for new indication in U.S.

Aug. 23, 1996

Carvedilol approved for CHF indication in Spanish market

Aug. 23, 1996

NeoRx's Verluma approved for U.S. market

Aug. 23, 1996

Aredia earns U.S. approval for new indication

Aug. 23, 1996

Ethyol extended labeling approved

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...